alexa Increasing Oxygen in Hypoxic Tumors
ISSN: 2161-1459

Journal of Clinical & Experimental Pharmacology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Increasing Oxygen in Hypoxic Tumors

John L. Gainer1,2* and Miles F. Lankford3

1Chief Scientific Consultant, Diffusion Pharmaceuticals LLC

2Department of Chemical Engineering (Emeritus),University of Virginia

3Molecular Assessments and Preclinical Studies (MAPS) Core, University of Virginia , Charlottesville, VA

*Corresponding Author:
Dr. J. L. Gainer
Chief Scientific Consultant Diffusion Pharmaceuticals
LLC 2020 Avon Court,
#4 Charlottesville, VA 22902, USA
Tel: 434-220-0718
Fax: 434-220-0722
E-mail: [email protected]

Received November 28, 2011; Accepted December 13, 2011; Published December 19, 2011

Citation: Gainer JL, Lankford MF (2011) Increasing Oxygen in Hypoxic Tumors. Clinic Experiment Pharmacol 1:103. doi: 10.4172/2161-1459.1000103

Copyright: © 2011 Gainer JL, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Background: Tumors are frequently hypoxic, affecting both chemotherapy and radiotherapy. Trans sodium crocetinate (TSC), a novel pharmaceutical agent, causes increases in oxygen levels of hypoxic tissues. It has also been shown, in animal models of cancer, that radiotherapy is more effective when used in conjunction with TSC. An increase in tumor oxygen should also affect the HIF-1α pathway. Thus, an in vitro study of that pathway in human glioblastoma cells was performed. Methods: This study involved the use of quantitative real time polymerase chain reaction technology and human glioblastoma multiforme cells. The cells were cultured under both hypoxic and normoxic conditions. Results: The inclusion of TSC in the media of the cells resulted in some genes in the HIF-1α pathway being either up- or down-regulated in a statistically-significant manner. These changes were opposite to those which occurred when the same cells were grown under hypoxic conditions but without TSC. In addition, those same genes reacted in an opposite manner when the cells were grown with TSC but under a normal oxygen environment. Conclusions: These results support previous observations that TSC reduces hypoxia in tumor cells. Since TSC caused statistical differences in gene expression under hypoxia different from those caused under normoxia, it suggests that there is not a direct effect of TSC on the HIF-1α pathway. Rather, TSC alters the gene expression due to a change in the response of the genes to different oxygen levels. These data also correlate with previous in vivo studies which show that TSC increases oxygen to hypoxic tissue but not to normal tissue. Thus, these data, combined with previous studies of animal cancer models, strongly suggest that TSC has the ability to increase cellular oxygen in tumor cells. Such a physiological change can be beneficial with combined with radiotherapy for cancer.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version